<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>识林 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-19T07:28:58+08:00</updated>
  <subtitle>服务于制药行业企业、机构及人员的知识与管理平台</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>FDA 发布 34 篇具体产品指南，首个口服植物药 BE 建议出台</title>
    <updated>2020-11-19T06:44:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/XP-31zNgz0zLJpDACeKnrQ</id>
    <link href="https://mp.weixin.qq.com/s/XP-31zNgz0zLJpDACeKnrQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉瑞新冠疫苗完成有效性分析，不日将提交紧急使用申请</title>
    <updated>2020-11-19T06:44:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/qhjoUuvRxGBbyJ4P2kEmzQ</id>
    <link href="https://mp.weixin.qq.com/s/qhjoUuvRxGBbyJ4P2kEmzQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>透明带来信任：FDA 宣布披露用于支持紧急使用授权的审评信息</title>
    <updated>2020-11-18T06:30:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/AiWto0t5JbaLga5a_LZqTQ</id>
    <link href="https://mp.weixin.qq.com/s/AiWto0t5JbaLga5a_LZqTQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辅料元素杂质数据库企业联盟：减轻 ICH Q3D 检测负担</title>
    <updated>2020-11-18T06:30:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/Nnq2dDIvNj6_SOk8i6IEvw</id>
    <link href="https://mp.weixin.qq.com/s/Nnq2dDIvNj6_SOk8i6IEvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Moderna 宣布新冠疫苗保护效力达 94%，或可预防严重疾病</title>
    <updated>2020-11-17T06:47:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/mGuY5NJB4VyL7Vz3MJvi4Q</id>
    <link href="https://mp.weixin.qq.com/s/mGuY5NJB4VyL7Vz3MJvi4Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从两篇公开文献看 FDA 和医学专家对早产治疗药撤市的辩论</title>
    <updated>2020-11-17T06:47:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/qpfNtVtd_ZhQjFapxnb46w</id>
    <link href="https://mp.weixin.qq.com/s/qpfNtVtd_ZhQjFapxnb46w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一周回顾：疫苗上市许可持有人质量年报要求，药品网络销售监管办法，WHO研究和开发设施GMP指南，FDA增强临床试验人群多样性指南</title>
    <updated>2020-11-16T06:44:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/GA_ulti-OMW86AgLE8UHqg</id>
    <link href="https://mp.weixin.qq.com/s/GA_ulti-OMW86AgLE8UHqg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>WHO 发布药品研发期间的 GMP 指南草案</title>
    <updated>2020-11-16T06:44:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/aEcCe22UMYQi8ZVGnYuHOg</id>
    <link href="https://mp.weixin.qq.com/s/aEcCe22UMYQi8ZVGnYuHOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【周末杂谈】精英与百姓</title>
    <updated>2020-11-15T06:20:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/z5mdqyvAuAYR7nXe-Tz65g</id>
    <link href="https://mp.weixin.qq.com/s/z5mdqyvAuAYR7nXe-Tz65g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>企业元素杂质风险评估有所改善，仍有进步空间</title>
    <updated>2020-11-14T06:42:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/YDgme_ld9nwKB9QoVPCGVg</id>
    <link href="https://mp.weixin.qq.com/s/YDgme_ld9nwKB9QoVPCGVg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>美参议员要求 FDA 提供疫情期间国外药品检查状况与恢复计划</title>
    <updated>2020-11-13T06:43:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/FacALNGt7poKQepfUX7eIQ</id>
    <link href="https://mp.weixin.qq.com/s/FacALNGt7poKQepfUX7eIQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA 处方药收费新一轮谈判关注生产检查和人为因素方案等问题</title>
    <updated>2020-11-13T06:43:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/K37F7R6feXIBfIExK6RdHA</id>
    <link href="https://mp.weixin.qq.com/s/K37F7R6feXIBfIExK6RdHA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>礼来新冠治疗性抗体获紧急授权，GMP 合规要求为授权条件之一</title>
    <updated>2020-11-12T06:38:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/5461P-VHoy58l5Rj0nfTKQ</id>
    <link href="https://mp.weixin.qq.com/s/5461P-VHoy58l5Rj0nfTKQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>欧洲众协会对欧盟无菌 GMP 附录修订提出更多改进</title>
    <updated>2020-11-12T06:38:50+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/cvN5awQjdKz400KIYYcpJw</id>
    <link href="https://mp.weixin.qq.com/s/cvN5awQjdKz400KIYYcpJw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA 相关负责人在仿制药会上小结 2020 年工作</title>
    <updated>2020-11-11T06:36:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/tum0VnU8fVquCY-qG_Mxxg</id>
    <link href="https://mp.weixin.qq.com/s/tum0VnU8fVquCY-qG_Mxxg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA 定稿指南为增强临床试验人群多样性提供建议</title>
    <updated>2020-11-11T06:36:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/Aj_MvRHwlzRcEt2Vm6CXEw</id>
    <link href="https://mp.weixin.qq.com/s/Aj_MvRHwlzRcEt2Vm6CXEw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>WHO 发布试验用药品 GMP 指南修订草案</title>
    <updated>2020-11-10T06:40:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/qb4MYWyti0CdyWhj9Ms8Bw</id>
    <link href="https://mp.weixin.qq.com/s/qb4MYWyti0CdyWhj9Ms8Bw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉瑞新冠疫苗III期期中分析显示90%保护力，后续可期待些什么？</title>
    <updated>2020-11-10T06:40:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/hJET1HSVxOvGCBbFaJQ2CA</id>
    <link href="https://mp.weixin.qq.com/s/hJET1HSVxOvGCBbFaJQ2CA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>